concept

SENESCENT MICROGLIA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SENESCENT MICROGLIA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

40Connections

8Hypotheses

0Analyses

28Outgoing

12Incoming

9Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	SENESCENT MICROGLIA
Key Genes/Proteins	INFLAMMATORY FACTORS

Pathway Diagram

graph TD
    SENESCENT_MICROGLIA["SENESCENT MICROGLIA"]
    SENESCENT_MICROGLIA -->|"co_expressed_with"| TREM2["TREM2"]
    SENESCENT_MICROGLIA -->|"expressed in"| SASP["SASP"]
    SENESCENT_MICROGLIA -->|"risk_factor_for"| Neurodegenerative_Diseases["Neurodegenerative Diseases"]
    SENESCENT_MICROGLIA -->|"contributes to"| Brain_Inflammation["Brain Inflammation"]
    SENESCENT_MICROGLIA -->|"contributes to"| Alzheimer_s_Disease["Alzheimer's Disease"]
    SENESCENT_MICROGLIA -->|"contributes to"| Inflammaging["Inflammaging"]
    SENESCENT_MICROGLIA -->|"activates"| brain_inflammation["brain inflammation"]
    SASP -->|"expressed in"| SENESCENT_MICROGLIA
    ABT_737["ABT-737"] -->|"downregulates"| SENESCENT_MICROGLIA
    TGM2["TGM2"] -->|"upregulates"| SENESCENT_MICROGLIA
    TREM2 -->|"regulates"| SENESCENT_MICROGLIA
    lactic_acid["lactic acid"] -.biomarker for.-> SENESCENT_MICROGLIA

Outgoing (28)

Target	Relation	Type	Str
SASP	associated_with	phenotype	0.95
Brain Aging	associated_with	process	0.90
SASP	expressed_in	process	0.90
Pro-inflammatory cytokines	upregulates	pathway	0.90
Senescence-Associated Secretory Phenotype	associated_with	phenotype	0.90
Neuroinflammation	associated_with	phenotype	0.90
Neurodegenerative Diseases	risk_factor_for	disease	0.90
AGING	promotes	process	0.90
TREM2	co_expressed_with	gene	0.90
Cognitive Decline	associated_with	phenotype	0.87
Alzheimer Disease	implicated_in	disease	0.85
Brain Inflammation	contributes_to	process	0.85
Inflammaging	contributes_to	process	0.85
Alzheimer's Disease	contributes_to	disease	0.85
NEURODEGENERATION	risk_factor_for	process	0.85
Alzheimer'S Disease	contributes_to	disease	0.85
ALZHEIMER'S DISEASE	contributes_to	disease	0.80
PARKINSON'S DISEASE	contributes_to	disease	0.80
ALS	contributes_to	disease	0.80
Alzheimer's Disease	risk_factor_for	disease	0.80
brain aging	promotes	process	0.80
INFLAMMATORY FACTORS	secretes	protein	0.80
Microglial Heterogeneity	contributes_to	phenotype	0.80
hippocampus	expressed_in	brain_region	0.70
amyotrophic lateral sclerosis	implicated_in	disease	0.70
brain inflammation	activates	process	0.70
brain inflammation	associated_with	process	0.70
Alzheimer's disease	associated_with	disease	0.70

Incoming (12)

Source	Relation	Type	Str
SASP	expressed_in	process	0.95
SASP	associated_with	process	0.95
ABT-737	downregulates	drug	0.92
TGM2	upregulates	gene	0.90
Aging	associated_with	process	0.85
Abt-737	associated_with	drug	0.85
Amyloidosis	associated_with	disease	0.85
TREM2	regulates	gene	0.80
Tauopathy	associated_with	disease	0.80
ABT-737	inhibits	drug	0.70
TREM2	expressed_in	gene	0.70
lactic acid	biomarker_for	protein	0.70

Targeting Hypotheses (8)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Senescent Microglia Resolution via Maresins-Senolytics Combi	0.784	neurodegeneration	Neuroinflammation resolution mechanisms
SASP-Secreted MMP-9 from Senescent Microglia Generates Patho	0.682	ALS	What are the mechanisms by which microgl
TREM2-Dependent Senescent Microglia Disrupt Astrocyte Commun	0.600	neurodegeneration	Gene expression changes in aging mouse b
Timed Senolytic Therapy Eliminates p16^Ink4a/p21^Cip1-Senesc	0.564	neuroinflammation	What molecular mechanisms drive the tran
Severely Depleted mtDNA and Impaired OXPHOS Defines Senescen	0.520	neurodegeneration	How can senescent microglia be molecular

GATA4 Stabilization and NF-κB Co-activation Identifies Senes	0.520	neurodegeneration	How can senescent microglia be molecular
Loss of Nuclear Lamin B1 Distinguishes Senescent Microglia f	0.520	neurodegeneration	How can senescent microglia be molecular
Disease-Elevated CHI3L1/CHIT1 Chitinases Are Biomarkers and	0.500	ALS	What are the mechanisms by which microgl

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (9)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Proposed experiment from debate on Senolytics targeting p16/p21+ senes	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
cGAS-STING Pathway Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,100,000
Microglial Aging and Immune Memory in Neurodegeneration — Training the	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$2,960,000
Microglial Contributions to Huntington's Disease Pathogenesis	validation	Neuroinflammation	0.400	0.50	human	proposed	$2,960,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
Traumatic Brain Injury and Alzheimer's Disease Relationship	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$3,000,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the S [PMID:37738560]	Justice JN, Leng XI, LeBrasseur NK, Tchk	J Gerontol A Biol Sci Med Sci	2024	1
Sex differences in autophagy-mediated diseases: toward precision medicine. [PMID:32264724]	Shang D, Wang L, Klionsky DJ, Cheng H, Z	Autophagy	2021	1
Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populatio [PMID:33144684]	He D, Wang D, Lu P, Yang N, Xue Z, Zhu X	Oncogene	2021	1
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells [PMID:26657143]	Chang J, Wang Y, Shao L, Laberge RM, Dem	Nat Med	2016	1
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. [PMID:25754370]	Zhu Y, Tchkonia T, Pirtskhalava T, Gower	Aging Cell	2015	1
Senolytic elimination of therapy-induced senescent cells by ABT-263 improves che [PMID:41423036]	Zhang D, Zhu J, Zou R, Zhang H, Yu BP, L	Biochemical pharmacology	2026	0
Comprehensive assessment of the genomic stability of human induced pluripotent s [PMID:41877289]	Zhang K, Na T, Jia C, Yuan X, Guo M, Yan	Stem cell research & therapy	2026	0
Characterization of the Direct and Indirect Inhibition of Apoptosis by Full-Leng [PMID:41589352]	Elsner C, Epasto LM, Cieren A, Gendreizi	Chembiochem : a European journ	2026	0
Exploring the key molecular mechanisms and immune microenvironment of oxidative [PMID:41591671]	Cai Z, Li J, Li T, Peng Q	Discover oncology	2026	0
Navitoclax acts synergistically with irradiation to induce apoptosis in preclini [PMID:41430412]	Vardon A, Haston S, Hamdi H, Cooksley G,	Scientific reports	2025	0
Combination of senolytic and pro-resolving mediator shows synergistic benefit in [PMID:synthetic_19]	Unknown	Nat Aging	2024	0
Senolytic treatment diminishes microglia and decreases severity of experimental [PMID:39487537]	Drake SS, Zaman A, Gianfelice C, Hua EM,	Journal of neuroinflammation	2024	0
CSF markers of microglial senescence predict cognitive decline in Alzheimer's di [PMID:synthetic_20]	Unknown	Ann Neurol	2023	0
Senescent microglia accumulate in Alzheimer's disease brains and drive neuroinfl [PMID:synthetic_16]	Unknown	Nature	2023	0
Maresin 1 reprograms microglia from pro-inflammatory to phagocytic phenotype via [PMID:synthetic_17]	Unknown	Cell	2022	0
Senescent cells provide beneficial functions in tissue repair and immune surveil [PMID:synthetic_21]	Unknown	Nat Rev Immunol	2022	0
ABT-263 causes dose-limiting thrombocytopenia in cancer trials via BCL-xL inhibi [PMID:synthetic_22]	Unknown	J Clin Oncol	2020	0
The Beclin 1 network regulates autophagy and apoptosis. [PMID:21311563]	Kang R, Zeh HJ, Lotze MT, Tang D	Cell death and differentiation	2011	0
The landscape of somatic copy-number alteration across human cancers. [PMID:20164920]	Beroukhim R, Mermel CH, Porter D, Wei G,	Nature	2010	0
Serine/threonine protein phosphatases in apoptosis. [PMID:12127881]	Klumpp S, Krieglstein J	Current opinion in pharmacolog	2002	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning SENESCENT MICROGLIA in their description or question text

GATA4 Stabilization and NF-κB Co-activation Identifies Senescent Microglia

Score: 0.520 · neurodegeneration · 2026-04-22

## Mechanistic Overview GATA4 Stabilization and NF-κB Co-activation Identifies Senescent Microglia starts from the claim

Loss of Nuclear Lamin B1 Distinguishes Senescent Microglia from Inflammatory Act

Score: 0.520 · neurodegeneration · 2026-04-22

## Mechanistic Overview Loss of Nuclear Lamin B1 Distinguishes Senescent Microglia from Inflammatory Activation starts f

Disease-Elevated CHI3L1/CHIT1 Chitinases Are Biomarkers and Partial Compensators

Score: 0.500 · ALS · 2026-04-26